Abstract A novel series of aryloxyalkyl derivatives of imidazole and 1, 2, 4-triazole, 17–31, was designed and synthesized as inhibitors of heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2). Some of these compounds were found to be good inhibitors of HO-1, in particular those carrying an imidazole moiety as azolyl group and a 3-bromo or 4- iodophenyl as aryl moiety. The most potent compounds 6 and 30 were selected and ...